Stephen J. Schuster

faculty photo
Professor of Medicine at the Hospital of the University of Pennsylvania
Attending Physician, Department of Medicine, Division of Hematology-Oncology, Hospital of the University of Pennsylvania
Director, Lymphoma Translational Research, Abramson Cancer Center of the University of Pennsylvania
Department: Medicine

Contact information
Division of Hematology Oncology
Perelman Center for Advanced Medicine
12th Floor, South Pavilion
Office #12-157
3400 Civic Center Blvd
Philadelphia, PA 19104
Office: (215) 614-1846
Fax: 215-615-5888
Education:
B.S. (Psychology)
Saint Joseph's University, Philadelphia, PA, 1976.

Laboratory Research Technician, Division of Rheumatology, Hahnemann Medical College and Hospital, Philadelphia, PA, 1977.
M.D.
Jefferson Medical College, Philadelphia, PA, 1981.
Permanent link
 

Description of Itmat Expertise

Application of immunology to therapeutic approaches for lymphomas and chronic lymphocytic leukemia. Imaging of lymphomas and chronic lymphocytic leukemia.

Selected Publications

Ruella, Marco. Kenderian, Saad S. Shestova, Olga. Fraietta, Joseph A. Qayyum, Sohail. Zhang, Qian. Maus, Marcela V. Liu, Xiaobin. Nunez-Cruz, Selene. Klichinsky, Michael. Kawalekar, Omkar U. Milone, Michael. Lacey, Simon F. Mato, Anthony. Schuster, Stephen J. Kalos, Michael. June, Carl H. Gill1, Saar. Wasik, Mariusz A. : The Addition of the BTK Inhibitor Ibrutinib to Anti-CD19 Chimeric Antigen Receptor T Cells (CART19) Improves Responses against Mantle Cell Lymphoma. Clinical Cancer Research. 22(11): 2684-96, Jun 1 2016.

Williams, Michael E. Hong, Fangxin. Gascoyne, Randy D. Wagner, Lynne I. Krauss, John C. Habermann, Thomas M. Swinnen, Lode J. Schuster, Stephen J. Peterson, Christopher G. Sborov, Mark D. Martin, Eric. Weiss, Matthias. Ehmann, W. Christopher. Horning, Sandra J. Kahl, Brad S. : Rituximab extended schedule or retreatment trial for low tumour burden non-follicular indolent B-cell non-Hodgkin lymphomas: Eastern Cooperative Oncology Group Protocol E4402. British Journal of Haematology. Mar 11 2016 Notes: [Epub ahead of print]

Yam, Clinton. Landsburg, Daniel J. Lin, Xinyi. Mato, Anthony. Svoboda, Jakub. Loren, Alison. Frey, Noelle. Stadtmauer, Edward A. Porter, David. Schuster, Stephen J. Nasta, Sunita D.: Autologous stem cell transplantation in first complete remission may not extend progression free survival in patients with peripheral T cell lymphomas. American Journal of Hematology. Mar 25 2016 Notes: [Epub ahead of print]

Ruan, Jia. Martin, Peter. Shah, Bijal. Schuster, Stephen J. Smith, Sonali M. Furman, Richard R. Christos, Paul. Rodriguez, Amelyn. Svoboda, Jakub. Lewis, Jessica. Katz, Orel. Coleman, Morton. Leonard, John P.: Lenalidomide plus Rituximab as Initial Treatment for Mantle-Cell Lymphoma. The New England Journal of Medicine. 373(18): 1835-44, Nov 5 2015.

Luskin, Marlise R. Heil, DS. Tan, KS. Choi, Sarah. Stadtmauer, Edward A. Schuster, Stephen J. Porter, David L. Vonderheide, Robert H. Bagg, Adam. Heitjan, Daniel F. Tsai, Donald E. Reshef, Ran.: The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder. American Joural of Transplant. 15(10): 2665-73, Oct 2015 Notes: [Epub ahead of print]May 18, 2015.

Paul, Thomas M. Liu, Stephen V. Chong, Elise A. Luger, Selina M. Porter, David L. Schuster, Stephen J. Tsai, Donald E. Nasta, Sunita D. Loren, Alison. Frey, Noelle. Perl, Alexander. Cohen, Adam D. Weiss, Brendan M. Stadtmauer, Edward A. Vogl, Dan T.: Outpatient Autologous Stem Cell Transplantation for Patients With Myeloma. Clinical Lymphoma Myeloma and Leukemia. 15(9): 536-40, Sep 2015.

Huntington, Scott F. Nasta, Sunita D. Schuster, Stephen J. Doshi, Jalpa A. Svoboda, Jakub. : Utility of interim and end-of-treatment [18F]-fluorodeoxyglucose positron emission tomography-computed tomography in frontline therapy of patients with diffuse large B-cell lymphoma. Leukemia & Lymphoma. 56(9): 2579-84, Sep 2015.

Howlett, Christina. Snedecor, Sonya J. Landsburg, Daniel J. Svoboda, Jakub. Chong, Elis A. Schuster, Stephen J. Nasta, Sunita D. Feldman, Tatyana. Rago, Allison. Walsh, Kristy M. Weber, Scott. Goy, Andre. Mato, Anthony.: Front-line, dose-escalated immunochemotherapy is associated with a significant progression-free survival advantage in patients with double-hit lymphomas: a systematic review and meta-analysis. British Journal of Haematology. 170(4): 504-14, Aug 2015.

Mato, Anthony R. Foon, Kenneth A. Feldman, Tatyana. Schuster, Stephen J. Svoboda, Jakub. Chow, Kar Fai. Valentinetti, Marisa. Mrkulic, Mary. Azzollini, Kelly. Gadaleta, Gabriella. Bhattacharyya, Pritish K. Zenreich, Joshua. Pascual, Lauren-Nicole. Yannotti, Kara. Kdiry, Sabrina. Howlett, Christina. Strelec, Lauren. Porter, David. Bejot, Coleen. Goy, André.: Reduced-dose fludarabine, cyclophosphamide and rituximab (FCR-Lite) plus lenalidomide, followed by lenalidomide consolidation/maintenance, in previously untreated chronic lymphocytic leukemia. American Journal of Hematology. 90(6): 487-92, Jun 2015.

Chong, Elise A. Ahmadi, Tahamtan. Aqui, Nicole A. Svoboda, Jakub. Nasta, Sunita D. Mato, Anthony R. Walsh, Kristy M. Schuster, Stephen J.: Combination of lenalidomide and rituximab overcomes rituximab-resistance in patients with indolent B-cell and mantle cell lymphomas. Clinical Cancer Research. 21(8): 1835-42, Apr 15 2015.

back to top
Last updated: 07/14/2016
The Trustees of the University of Pennsylvania